Single Cell Sequencing Market
Single Cell Sequencing Market Forecasts to 2032 – Global Analysis By Product (Instruments, Reagents & Consumables, Software & Services and Other Products), Cell Type, Workflow, Technology, Application, End User and By Geography
According to Stratistics MRC, the Global Single Cell Sequencing Market is accounted for $2.1 billion in 2025 and is expected to reach $5.4 billion by 2032 growing at a CAGR of 14.2% during the forecast period. Single-cell sequencing is an advanced genomic technique used to analyze the genetic material of individual cells, providing detailed insights into cellular diversity, gene expression, and function. Unlike traditional bulk sequencing, which averages signals from multiple cells, single-cell sequencing captures variations at the single-cell level, revealing heterogeneity within tissues and complex biological systems. This technology involves isolating individual cells, amplifying their nucleic acids, and sequencing DNA or RNA to study genomic, transcriptomic, or epigenomic profiles. It plays a crucial role in understanding developmental biology, cancer evolution, immune responses, and neurological disorders, enabling precision medicine and targeted therapeutic advancements.
Market Dynamics:
Driver:
Rising demand in precision medicine, oncology & immunology
Scientists are using single-cell platforms to uncover cellular heterogeneity, identify rare cell populations, and map immune responses in cancer and autoimmune diseases. Integration with spatial transcriptomics and multi-omics tools is improving resolution and biological insight. Pharmaceutical companies are leveraging single-cell data to optimize drug targets and biomarker discovery. These capabilities are propelling innovation across personalized medicine and translational research.
Restraint:
Complexity of data analysis and bioinformatics bottlenecks
High-dimensional datasets require advanced computational tools and skilled personnel for preprocessing, normalization, and interpretation. Lack of standardized pipelines and annotation frameworks slows reproducibility and cross-study comparison. Storage and processing costs remain high for large-scale experiments. Smaller labs and hospitals face challenges in integrating single-cell workflows into existing infrastructure. These constraints continue to hinder operational efficiency and platform adoption.
Opportunity:
Increasing research funding & government support
National genomics programs and cancer moonshots are allocating resources to single-cell platforms for disease mapping and therapeutic development. Public-private partnerships are supporting tool development, training, and data sharing across academic and clinical networks. Investment in open-source bioinformatics and cloud-based analysis platforms is improving accessibility and scalability. These trends are fostering long-term growth across basic science, diagnostics, and drug development.
Threat:
Lack of standardization and reproducibility
Variability in sample preparation, library construction, and sequencing depth can lead to inconsistent results. Absence of universal benchmarks and reference datasets complicates cross-platform comparison. Reproducibility challenges slow regulatory acceptance and clinical translation. Journals and funding bodies are increasing scrutiny around data quality and transparency. These risks continue to hamper confidence and downstream utility in high-impact applications.
Covid-19 Impact:
The pandemic accelerated interest in single cell sequencing as researchers sought to understand immune responses and viral pathogenesis. Single-cell platforms were used to profile COVID-19 patient samples and identify immune signatures linked to severity and recovery. Investment in infectious disease research and immunology surged across public and private sectors. Remote collaboration and cloud-based analysis tools gained traction during lab closures. Post-pandemic strategies now include single-cell sequencing as part of long-term preparedness and biomedical innovation. These shifts are accelerating integration into clinical and translational workflows.
The instruments segment is expected to be the largest during the forecast period
The instruments segment is expected to account for the largest market share during the forecast period due to their foundational role in enabling sample isolation, library preparation, and sequencing across single-cell workflows. Platforms such as microfluidics, droplet-based systems, and laser capture technologies are being adopted across academic and commercial labs. Vendors are offering modular instruments that support multi-omics and spatial integration. Demand for high-throughput, low-input systems is rising across oncology, neurology, and stem cell research. These capabilities are boosting instrument segment dominance across global sequencing infrastructure.
The downstream data analysis segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the downstream data analysis segment is predicted to witness the highest growth rate as researchers seek scalable and interpretable insights from high-dimensional single-cell datasets. Bioinformatics platforms are enabling clustering, trajectory inference, and differential expression analysis across cell populations. Integration with machine learning and cloud computing is improving speed and reproducibility. Vendors are launching user-friendly interfaces and automated pipelines for non-specialist users. Demand for real-time, collaborative analysis is rising across multi-site studies and translational programs. These dynamics are accelerating growth across data-centric sequencing applications.
Region with largest share:
During the forecast period, the North America region is expected to hold the largest market share due to its advanced research infrastructure, funding ecosystem, and vendor presence. U.S. institutions are deploying single-cell platforms across cancer centers, academic labs, and biotech firms. NIH and private foundations are funding large-scale cell atlas and immunology projects. Presence of leading instrument and software vendors is driving innovation and standardization. Regulatory clarity and clinical trial integration are supporting translational adoption. These factors are boosting North America’s leadership in single-cell sequencing deployment.
Region with highest CAGR:
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR as genomics investment, healthcare digitization, and academic expansion converge. Countries like China, Japan, South Korea, and India are scaling single-cell platforms across oncology, infectious disease, and stem cell research. Government-backed programs are supporting infrastructure, training, and data sharing across institutions. Local vendors are launching affordable instruments and cloud-based analysis tools tailored to regional needs. Demand for precision diagnostics and personalized therapies is rising across public and private sectors. These trends are accelerating regional growth across single-cell sequencing ecosystems.
Key players in the market
Some of the key players in Single Cell Sequencing Market include 10x Genomics, Illumina, Thermo Fisher Scientific, QIAGEN, Fluidigm, Takara Bio, Bio-Rad Laboratories, Roche, BGI Group / Complete Genomics, Parse Biosciences, Singleron Biotechnologies, Mission Bio, STRATEC SE and Agilent Technologies.
Key Developments:
In April 2025, 10x Genomics introduced new enhancements to its Chromium and Visium platforms, supporting multi-omic single-cell analysis. These upgrades enabled researchers to simultaneously profile gene expression, epigenetic markers, and spatial context, improving resolution and throughput for oncology, immunology, and neuroscience applications.
In August 2024, Illumina announced a new research partnership with the Broad Institute of MIT and Harvard to accelerate single-cell sequencing applications. The collaboration focuses on multiomics integration, enabling researchers to combine transcriptomic, epigenomic, and spatial data for deeper insights into cell function and disease mechanisms.
Products Covered:
• Instruments
• Reagents & Consumables
• Software & Services
• Other Products
Cell Types Covered:
• Human Cells
• Animal Cells
• Microbial Cells
• Other Cell Types
Workflows Covered:
• Sample Preparation
• Single Cell Isolation
• Library Preparation
• Sequencing
• Downstream Data Analysis
• Other Workflows
Technologies Covered:
• Next-Generation Sequencing (NGS)
• Single-Molecule Real-Time (SMRT) Sequencing
• Microfluidics
• PCR-Based Techniques
• Flow Cytometry
• Microscopy-Based Methods
• Other Technologies
Applications Covered:
• Oncology
• Immunology
• Neurology
• Stem Cell Research
• Non-Invasive Prenatal Testing (NIPT)
• In Vitro Fertilization (IVF)
• Other Applications
End Users Covered:
• Academic & Research Institutes
• Pharmaceutical & Biotechnology Companies
• Clinical & Diagnostic Labs
• Contract Research Organizations (CROs)
• Other End-Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Technology Analysis
3.8 Application Analysis
3.9 End User Analysis
3.10 Emerging Markets
3.11 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Single Cell Sequencing Market, By Product
5.1 Introduction
5.2 Instruments
5.3 Reagents & Consumables
5.4 Software & Services
5.5 Other Products
6 Global Single Cell Sequencing Market, By Cell Type
6.1 Introduction
6.2 Human Cells
6.3 Animal Cells
6.4 Microbial Cells
6.5 Other Cell Types
7 Global Single Cell Sequencing Market, By Workflow
7.1 Introduction
7.2 Sample Preparation
7.3 Single Cell Isolation
7.4 Library Preparation
7.5 Sequencing
7.6 Downstream Data Analysis
7.7 Other Workflows
8 Global Single Cell Sequencing Market, By Technology
8.1 Introduction
8.2 Next-Generation Sequencing (NGS)
8.3 Single-Molecule Real-Time (SMRT) Sequencing
8.4 Microfluidics
8.5 PCR-Based Techniques
8.6 Flow Cytometry
8.7 Microscopy-Based Methods
8.8 Other Technologies
9 Global Single Cell Sequencing Market, By Application
9.1 Introduction
9.2 Oncology
9.3 Immunology
9.4 Neurology
9.5 Stem Cell Research
9.6 Non-Invasive Prenatal Testing (NIPT)
9.7 In Vitro Fertilization (IVF)
9.8 Other Applications
10 Global Single Cell Sequencing Market, By End User
10.1 Introduction
10.2 Academic & Research Institutes
10.3 Pharmaceutical & Biotechnology Companies
10.4 Clinical & Diagnostic Labs
10.5 Contract Research Organizations (CROs)
10.6 Other End-Users
11 Global Single Cell Sequencing Market, By Geography
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 Germany
11.3.2 UK
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia Pacific
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Australia
11.4.5 New Zealand
11.4.6 South Korea
11.4.7 Rest of Asia Pacific
11.5 South America
11.5.1 Argentina
11.5.2 Brazil
11.5.3 Chile
11.5.4 Rest of South America
11.6 Middle East & Africa
11.6.1 Saudi Arabia
11.6.2 UAE
11.6.3 Qatar
11.6.4 South Africa
11.6.5 Rest of Middle East & Africa
12 Key Developments
12.1 Agreements, Partnerships, Collaborations and Joint Ventures
12.2 Acquisitions & Mergers
12.3 New Product Launch
12.4 Expansions
12.5 Other Key Strategies
13 Company Profiling
13.1 10x Genomics
13.2 Illumina
13.3 Thermo Fisher Scientific
13.4 QIAGEN
13.5 Fluidigm
13.6 Takara Bio
13.7 Bio-Rad Laboratories
13.8 Roche
13.9 BGI Group / Complete Genomics
13.10 Parse Biosciences
13.11 Singleron Biotechnologies
13.12 Mission Bio
13.13 STRATEC SE
13.14 Agilent Technologies
List of Tables
1 Global Single Cell Sequencing Market Outlook, By Region (2024-2032) ($MN)
2 Global Single Cell Sequencing Market Outlook, By Product (2024-2032) ($MN)
3 Global Single Cell Sequencing Market Outlook, By Instruments (2024-2032) ($MN)
4 Global Single Cell Sequencing Market Outlook, By Reagents & Consumables (2024-2032) ($MN)
5 Global Single Cell Sequencing Market Outlook, By Software & Services (2024-2032) ($MN)
6 Global Single Cell Sequencing Market Outlook, By Other Products (2024-2032) ($MN)
7 Global Single Cell Sequencing Market Outlook, By Cell Type (2024-2032) ($MN)
8 Global Single Cell Sequencing Market Outlook, By Human Cells (2024-2032) ($MN)
9 Global Single Cell Sequencing Market Outlook, By Animal Cells (2024-2032) ($MN)
10 Global Single Cell Sequencing Market Outlook, By Microbial Cells (2024-2032) ($MN)
11 Global Single Cell Sequencing Market Outlook, By Other Cell Types (2024-2032) ($MN)
12 Global Single Cell Sequencing Market Outlook, By Workflow (2024-2032) ($MN)
13 Global Single Cell Sequencing Market Outlook, By Sample Preparation (2024-2032) ($MN)
14 Global Single Cell Sequencing Market Outlook, By Single Cell Isolation (2024-2032) ($MN)
15 Global Single Cell Sequencing Market Outlook, By Library Preparation (2024-2032) ($MN)
16 Global Single Cell Sequencing Market Outlook, By Sequencing (2024-2032) ($MN)
17 Global Single Cell Sequencing Market Outlook, By Downstream Data Analysis (2024-2032) ($MN)
18 Global Single Cell Sequencing Market Outlook, By Other Workflows (2024-2032) ($MN)
19 Global Single Cell Sequencing Market Outlook, By Technology (2024-2032) ($MN)
20 Global Single Cell Sequencing Market Outlook, By Next-Generation Sequencing (NGS) (2024-2032) ($MN)
21 Global Single Cell Sequencing Market Outlook, By Single-Molecule Real-Time (SMRT) Sequencing (2024-2032) ($MN)
22 Global Single Cell Sequencing Market Outlook, By Microfluidics (2024-2032) ($MN)
23 Global Single Cell Sequencing Market Outlook, By PCR-Based Techniques (2024-2032) ($MN)
24 Global Single Cell Sequencing Market Outlook, By Flow Cytometry (2024-2032) ($MN)
25 Global Single Cell Sequencing Market Outlook, By Microscopy-Based Methods (2024-2032) ($MN)
26 Global Single Cell Sequencing Market Outlook, By Other Technologies (2024-2032) ($MN)
27 Global Single Cell Sequencing Market Outlook, By Application (2024-2032) ($MN)
28 Global Single Cell Sequencing Market Outlook, By Oncology (2024-2032) ($MN)
29 Global Single Cell Sequencing Market Outlook, By Immunology (2024-2032) ($MN)
30 Global Single Cell Sequencing Market Outlook, By Neurology (2024-2032) ($MN)
31 Global Single Cell Sequencing Market Outlook, By Stem Cell Research (2024-2032) ($MN)
32 Global Single Cell Sequencing Market Outlook, By Non-Invasive Prenatal Testing (NIPT) (2024-2032) ($MN)
33 Global Single Cell Sequencing Market Outlook, By In Vitro Fertilization (IVF) (2024-2032) ($MN)
34 Global Single Cell Sequencing Market Outlook, By Other Applications (2024-2032) ($MN)
35 Global Single Cell Sequencing Market Outlook, By End User (2024-2032) ($MN)
36 Global Single Cell Sequencing Market Outlook, By Academic & Research Institutes (2024-2032) ($MN)
37 Global Single Cell Sequencing Market Outlook, By Pharmaceutical & Biotechnology Companies (2024-2032) ($MN)
38 Global Single Cell Sequencing Market Outlook, By Clinical & Diagnostic Labs (2024-2032) ($MN)
39 Global Single Cell Sequencing Market Outlook, By Contract Research Organizations (CROs) (2024-2032) ($MN)
40 Global Single Cell Sequencing Market Outlook, By Other End-Users (2024-2032) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We offer complimentary customization of up to 15% with every purchase. To share your customization requirements, feel free to email us at info@strategymrc.com or call us on +1-301-202-5929. .
Please Note: Customization within the 15% threshold is entirely free of charge. If your request exceeds this limit, we will conduct a feasibility assessment. Following that, a detailed quote and timeline will be provided.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
